On the 10th, as the Mapo Agricultural and Marine Products Market in Seoul was closed due to a COVID-19 cluster infection, citizens visiting the nearby Mapo-gu Public Health Center's screening clinic lined up in a long queue for testing. As of midnight that day, the number of new confirmed cases was recorded at 1,594, influenced by a decrease in weekend testing volume. Photo by Kim Hyun-min kimhyun81@

On the 10th, as the Mapo Agricultural and Marine Products Market in Seoul was closed due to a COVID-19 cluster infection, citizens visiting the nearby Mapo-gu Public Health Center's screening clinic lined up in a long queue for testing. As of midnight that day, the number of new confirmed cases was recorded at 1,594, influenced by a decrease in weekend testing volume. Photo by Kim Hyun-min kimhyun81@

View original image

[Asia Economy Reporter Seo So-jeong] In the past two weeks, 83.1% of new adult COVID-19 cases occurred among the unvaccinated or partially vaccinated groups.


According to the COVID-19 Vaccination Response Promotion Team on the 11th, an analysis of vaccination status by age group showed that among 35,018 confirmed cases aged 18 and older in the past two weeks (September 12?25), 83.1% were from the unvaccinated or partially vaccinated groups.


In particular, among those under 60 years old with a low full vaccination rate, the unvaccinated or partially vaccinated groups accounted for more than 88% of all confirmed cases.


Additionally, through follow-up observation of 101,285 confirmed cases from May 1 to August 14, a comparison of severity based on COVID-19 vaccination status revealed that completing COVID-19 vaccination provided a 77.0% prevention effect against severe illness and a 73.7% prevention effect against death compared to the unvaccinated group.


The Promotion Team urged, "Those aged 60 and older, who are at high risk of severe COVID-19, must get vaccinated," and added, "For the effectiveness of COVID-19 vaccination, those who have completed the first dose should promptly complete the second dose."


Meanwhile, following the shortening of the messenger ribonucleic acid (mRNA) vaccine interval, those scheduled for their second dose between the second week of October and the second week of November were individually notified at the end of September that the interval has been adjusted from 6 weeks to 4?5 weeks. If individuals wish to change their second dose appointment date, they can directly modify it on the pre-registration website.


In particular, for the Moderna vaccine, since the 9th, it has been possible to individually change the second dose date after 4 weeks from the first dose, so those wishing to complete vaccination quickly can advance their second dose date through the pre-registration website.



From today, unvaccinated individuals aged 18 and older can also visit designated medical institutions without prior reservation and receive vaccination on the same day using available vaccine supplies.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing